Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2013
10/17/2013WO2013080055A3 Molecular display method
10/17/2013WO2012118323A9 Fusion protein comprising albumin and a retinol-binding protein
10/17/2013WO2012064883A9 Systems and methods for propionic acid production
10/17/2013US20130276172 Yield Increase in Plants Overexpressing the ACCDP Genes
10/17/2013US20130276171 Yield enhancement in plants by modulation of ap2 transcription factor
10/17/2013US20130276170 Fiber selective promoters
10/17/2013US20130276169 Isolated polynucleotides and polypeptides, and methods of using same for improving plant properties
10/17/2013US20130276168 Strategies for the transgenic manipulation of filamentous fungi
10/17/2013US20130276167 Plant transcription factors
10/17/2013US20130276165 Cotton variety fm 8270glb2
10/17/2013US20130276164 Cotton variety fm 1944glb2
10/17/2013US20130276163 Cotton variety st 5445llb2
10/17/2013US20130276162 Gene Constructs Comprising Nucleic Acids That Modulate Chlorophyll Biosynthesis And Uses Thereof
10/17/2013US20130276161 Transgenic plants with enhanced agronomic traits
10/17/2013US20130276159 Method and culture medium for preparing mammalian ovum or embryo in which zona pellucida has been thinned or eliminated, and method for fertilization using mammalian ovum prepared by same method
10/17/2013US20130276158 Methods and compositions for rna interference
10/17/2013US20130276157 Cyb5 and cyp17 mutations for alteration of 16-androstene steroid synthesis and reduced boar taint in pigs
10/17/2013US20130276156 Multiple Inducible Gene Regulation System
10/17/2013US20130276153 Production of Transgenic Avians Using Improved Retroviral Vectors
10/17/2013US20130274510 Synthesis of polyhydroxyalkanoates (pha) with thioester groups in the side chain
10/17/2013US20130274318 Novel Method of Protecting Islet Cells From Apoptosis during the Donor Harvesting Process
10/17/2013US20130274317 Derivatives of small interfering rnas and use thereof
10/17/2013US20130274316 Muc1 and galectin-3
10/17/2013US20130274315 Pro-angiogenic genes in ovarian tumor endothelial cell isolates
10/17/2013US20130274314 Mitochondrial targeted rna expression system and use thereof
10/17/2013US20130274313 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
10/17/2013US20130274312 siRNA Against p22phox
10/17/2013US20130274311 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 GENE
10/17/2013US20130274310 RNAi MODULATION OF SCAP AND THERAPEUTIC USES THEREOF
10/17/2013US20130274309 Compositions and methods for non-parenteral delivery of oligonucleotides
10/17/2013US20130274308 Modulation of factor 11 expression
10/17/2013US20130274293 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity
10/17/2013US20130274141 METHODS AND KITS FOR SYNTHESIS OF siRNA EXPRESSION CASSETTES
10/17/2013US20130274129 Tal-effector assembly platform, customized services, kits and assays
10/17/2013US20130274120 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
10/17/2013US20130274117 High-Throughput Single Cell Barcoding
10/17/2013US20130274113 Multiplex microfluidic device for selecting nucleic acid aptamers, and high throughput selection method for nucleic acid aptamers using same
10/17/2013US20130274112 Ligand screening and discovery
10/17/2013US20130273657 Nucleic acid molecules inducing rna interference, and uses thereof
10/17/2013US20130273656 Method to increase gene targeting frequency
10/17/2013US20130273655 ENGRAFTMENT POTENTIAL OF EMBRYONIC STEM CELLS AND PLURIPOTENT STEM CELLS USING MICRO RNAs
10/17/2013US20130273652 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
10/17/2013US20130273651 Differentiated cells suitable for human therapy
10/17/2013US20130273650 Vectors and methods for recombinant protein expression
10/17/2013US20130273647 Antigen-Specific T Cell Receptors and T Cell Epitopes
10/17/2013US20130273644 Nucleic acid amplification reaction station for disposable test devices
10/17/2013US20130273640 Nucleic acid sample preparation
10/17/2013US20130273638 Enhanced gene expression in algae
10/17/2013US20130273624 Coryneform bacterium transformant and process for producing phenol using the same
10/17/2013US20130273613 Hyperphotosynthetic Organisms
10/17/2013US20130273602 Strains of s.cerevisiae capable of growing in media with melibiose, stachyose and raffinose
10/17/2013US20130273601 Pentose and glucose fermenting yeast cell
10/17/2013US20130273562 1L1RL-1 as a Cardiovascular Disease Marker and Therapeutic Target
10/17/2013US20130273556 Modulation of gene expression by locked nucleic acids
10/17/2013US20130273555 Detoxification of Biomass Derived Acetate Via Metabolic Conversion to Ethanol, Acetone, Isopropanol, or Ethyl Acetate
10/17/2013US20130273551 Methods for identifying nucleic acid ligands
10/17/2013US20130273536 Combined chemical and genetic approaches for generation of induced pluripotent stem cells
10/17/2013US20130273526 DNA Polymerases Having Improved Labeled Nucleotide Incorporation Properties
10/17/2013US20130273170 Puumala virus full-length m segment-based dna vaccines
10/17/2013US20130273151 MicroRNA Fingerprints During Human Megakaryocytopoiesis
10/17/2013US20130273084 Use of a dna expression construct
10/17/2013US20130273038 Human cdr-grafted antibody and antibody fragment thereof
10/17/2013US20130273018 Recombinant human cln2 protein and methods of its production and use
10/17/2013US20130273001 Immunostimulation by chemically modified rna
10/17/2013US20130272998 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy
10/17/2013US20130272964 Molecules with extended half-lives, compositions and uses thereof
10/17/2013DE112011103527T5 Neue Fettsäure-Desaturasen, -Elongasen, -Elongations-Komponenten und Anwendungen davon New fatty acid desaturases, -Elongasen, -Elongations components and applications thereof
10/17/2013DE102012007491A1 Neue Enzyme New enzymes
10/17/2013DE102012007069A1 Producing artificial transcription activator-like effector genes from DNA fragments, comprises assembling individual fragments by ligation-independent cloning method using single-stranded 5' or 3' overhangs
10/16/2013EP2650376A1 Method for producing l-amino acid
10/16/2013EP2650374A1 Method for producing cadaverine
10/16/2013EP2650373A1 Method for producing cadaverine
10/16/2013EP2650369A1 Novel synthetic agonists of TLR9
10/16/2013EP2650368A1 Nucleic acid of formula (I): GlXmGn, or (II): ClXmCn, in particular as an immune-stimulating agent/adjuvant
10/16/2013EP2650367A1 Human monoclonal antibody
10/16/2013EP2650366A2 Rationally designed meganucleases with altered sequence specifity and DNA-binding affinity
10/16/2013EP2650365A1 Rationally designed meganucleases with altered sequence specificity and DNA-binding affinity
10/16/2013EP2650358A2 Microbes with an improved ability to produce ornithine and method for producing ornithine using same
10/16/2013EP2650357A2 Microorganisms for producing putrescine and method for producing putrescine using same
10/16/2013EP2650354A2 Bacillus subtilisin comprising one or more combinable mutations
10/16/2013EP2650307A1 IMMUNOLOGICAL cofilin-1 PROTEIN MEASUREMENT METHOD
10/16/2013EP2650304A1 Antimicrobial peptide multiblock copolymer to be expressed on surface of cells
10/16/2013EP2650018A2 Antibody-LIGHT fusion products for cancer therapeutics
10/16/2013EP2649887A2 High eicosapentaenoic acid producing strains of Yarrowia lipolytica
10/16/2013EP2649184A1 Fertile transgenic animals useful for producing antibodies bearing human variable regions
10/16/2013EP2649183A1 Bispecific aptamers mediating tumour cell lysis
10/16/2013EP2649182A2 Compositions and methods for increasing erythropoietin (epo) production
10/16/2013EP2649181A2 Double stranded oligonucleotide compounds comprising positional modifications
10/16/2013EP2649180A1 Methods for production of synthetic promoters with defined specificity
10/16/2013EP2649179A1 Recombinant bacteria having the ability to metabolize sucrose
10/16/2013EP2649178A1 Mgmt-based method for obtaining high yield of recombinant protein expression
10/16/2013EP2649094A1 Methods and compositions comprising il-7 receptor ligands
10/16/2013EP2649092A1 Modified protein body tags and production methods thereof
10/16/2013EP2648764A1 Multifunctional nanoparticles
10/16/2013EP2648763A2 Compositions and methods for inhibiting expression of klf-1 and bcl11a genes
10/16/2013EP2648744A2 Malaria vaccines based on pre-erythrocytic antigens from p. falciparum
10/16/2013EP2648743A2 Agents for increased resistance against oxidative stress conditions
10/16/2013EP2589657A9 Method for detection of target molecule
10/16/2013EP1720993B1 Method for producing l-threonine using bacteria belonging to the genus escherichia
10/16/2013CN203238276U Kit used for extracting miRNA (micro Ribose Nucleic Acid) from paraffin-embedded tissue
1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 4023